+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ADMA Biologics Inc - logo

ADMA Biologics is a late stage biopharmaceutical company that develops specialty plasma-based biologics for the treatment and prevention of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical study for the treatment of primary immune deficiency disease. ADMA Biologics was founded in 2004 and is based in Ramsey, New Jersey.

Biopharmaceuticals Contract Manufacturing Market Report 2026 - Product Thumbnail Image

Biopharmaceuticals Contract Manufacturing Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
From
Plasma Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Plasma Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 194 Pages
  • Global
From
Critical Care Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Critical Care Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Plasma Therapy Market Report 2025 - Product Thumbnail Image

Plasma Therapy Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Convalescent Plasma Therapy Market Report 2025 - Product Thumbnail Image

Convalescent Plasma Therapy Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
From
From
Loading Indicator